How long can I live taking selinexol?

The use of Selinexor (Selinexor) can prolong a patient's survival time, but the specific length of life depends on the patient's disease type, treatment response, disease progression, and personal physical condition. In the treatment of multiple myeloma and diffuse large B cell lymphoma, selinesol inhibits the nuclear export protein XPO1 and restores the function of tumor suppressor genes, which can significantly delay disease progression and improve survival.

In patients with multiple myeloma, especially those with relapsed or refractory disease who have failed multiple therapies, clinical trials have shown that the median progression-free survival (PFS) of patients treated with selinesol combined with dexamethasone is approximately3.7 months, and the median overall survival (OS) is approximately 8.6 months. This data suggests that selinesol is effective in controlling the disease, but how long a patient survives also depends on their sensitivity to treatment and management of side effects.

For patients with diffuse largeB cell lymphoma, especially those with relapsed or refractory disease who have failed multiple lines of therapy, selinesol provides a new treatment option. In related studies, the median progression-free survival of patients using selinesol was approximately 2.6 months, and the median overall survival was approximately 9.2 months. This therapeutic effect brings hope to patients, but efficacy and adverse reactions still need to be closely monitored during treatment.

It should be noted that survival time is based on the median value of statistical data, and the specific survival time varies depending on individual differences. Some patients may survive longer with treatment, while others may need to change treatment regimens due to disease progression or side effects. Patients should communicate with their doctors regularly during treatment to evaluate treatment effects and adjust the plan to obtain the best results.

xa0

Reference materials:

https://www.ncbi.nlm.nih.gov/